Cholinergic Nicotinic Systems in Alzheimer's Disease: Prospects for Pharmacological Intervention

ISSN： 1172-7047

Source： CNS Drugs, Vol.16, Iss.7, 2002-01, pp. : 485-500

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hypertension and Hypercholesterolaemia as Risk Factors for Alzheimer's Disease: Potential for Pharmacological Intervention

By Kivipelto M.

CNS Drugs, Vol. 16, Iss. 7, 2002-01 ,pp. : 435-444

Adis International

Access to resources Recommend Favorite

Inhibition of γ-Secretase as a Therapeutic Intervention for Alzheimer's Disease: Prospects, Limitations and Strategies

By Evin Geneviève Marijke Fleur Sernee Masters Colin L.

CNS Drugs, Vol. 20, Iss. 5, 2006-01 ,pp. : 351-372

Adis International

Access to resources Recommend Favorite

Non-cholinergic strategies for Alzheimer's disease

Inpharma, Vol. 1, Iss. 1363, 2002-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Alzheimer's disease: Targeting the Cholinergic System

Current Neuropharmacology, Vol. 14, Iss. 1, 2016-01 ,pp. : 101-115

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacological Management of Alzheimer's Disease

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 33, Iss. 1, 2003-03 ,pp. : 24-29

John Wiley & Sons Inc

Access to resources Recommend Favorite